M. Morganti et al., Von Willebrand's factor mediates the adherence of human tumoral cells to human endothelial cells and ticlopidine interferes with this effect, BIOMED PHAR, 54(8-9), 2000, pp. 431-436
The aim of this study was to explore whether von Willebrand's factor (vWF)
plays a role in the adhesion of human colon tumor cells to human endothelia
l cells in our coculture system.
Cell colony density was evaluated basally (endothelial plus colon tumor cel
ls) and following the addition of: purified vWF, vWF plus vWF-blocking anti
bodies, antibodies against various integrins and adhesion molecules (alpha
(2) b integrin, beta (1) integrin, beta (3), integrin, intercellular adhesi
on molecule-1, intercellular adhesion molecule-II, vitronectin receptor CD6
1 CD51, laminin alpha6/beta4 receptor), and various drugs inhibiting the he
mostatic system (ticlopidine, heparin, acetyl salicylic acid [ASA], defibro
tide, indobuphen, dipyridamole, sulfinpyrazone), Furthermore, VWF concentra
tion was measured in the supernatant fluid of the coculture system basally
and following the addition of the above-listed drugs, Cell colony density (
as measured by light absorption) increased by 33% following the addition of
VWF and returned to a value similar to the basal level with antibodies aga
inst vWF, while it did not change significantly following the addition of a
ntibodies against the other integrins or adhesion molecules tested. The sam
e parameter was reduced by 35% following the addition of ticlopidine, while
it showed a smaller or no change with the other drugs tested. Similarly, v
WF concentration in the cell coculture supernatant showed the greatest redu
ction (from 0.22 to 0.11 mg/mL) following the addition of ticlopidine. Thes
e data suggest that vWF mediates the adherence of human tumor cells to huma
n endothelial cells and that ticlopidine interferes with this effect. (C) 2
000 Editions scientifiques et medicales Elsevier SAS.